Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia

Chronic myeloid leukemia (CML) is a malignant disease that originates in the bone marrow and is designated by the presence of the Philadelphia (Ph+) chromosome, a translocation between chromosomes 9 and 22. Targeted therapy against CML commenced with the development of small-molecule tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Baran, Yusuf, Saydam, Guray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503471/
https://www.ncbi.nlm.nih.gov/pubmed/23180974
http://dx.doi.org/10.2147/JBM.S29132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503471/
https://www.ncbi.nlm.nih.gov/pubmed/23180974
http://dx.doi.org/10.2147/JBM.S29132

Ejemplares similares